PURPOSE: Leukemia inhibitory factor (LIF) is important for embryogenesis and implantation. We aimed to transfect LIF gene into the mouse endometrium. MATERIALS AND METHODS: Expression plasmids carried LIF and luciferase genes for transfer. After superovulation, 100 ICR mice were mated with vasectomized mice. Then LIF-liposome (Group 1) and luciferase-liposome complexes (Group 2) were injected into their uterine lumen (Day 0). Endometrial LIF and luciferase expressions were detected by reverse transcription-polymerase chain reaction on Days 0-4 post gene transfer. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control to normalize the gene transfection. RESULTS: LIF mRNA and luciferase activities reached the peak expression on Day 3. In Group 1, the ratios of LIF/GADPH on Days 1-4 were 0.414, 1.096, 1.162, and 0.782. In Group 2. LIF/GADPH on Days 1-4 were 0.24, 0.22, 0.35, and 0.32. CONCLUSIONS: Mouse endometrium could be effectively transfected with liposome-DNA mixtures. Endometrial LIF transfer via liposome may be effective in human.
PURPOSE:Leukemia inhibitory factor (LIF) is important for embryogenesis and implantation. We aimed to transfect LIF gene into the mouse endometrium. MATERIALS AND METHODS: Expression plasmids carried LIF and luciferase genes for transfer. After superovulation, 100 ICR mice were mated with vasectomized mice. Then LIF-liposome (Group 1) and luciferase-liposome complexes (Group 2) were injected into their uterine lumen (Day 0). Endometrial LIF and luciferase expressions were detected by reverse transcription-polymerase chain reaction on Days 0-4 post gene transfer. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control to normalize the gene transfection. RESULTS:LIF mRNA and luciferase activities reached the peak expression on Day 3. In Group 1, the ratios of LIF/GADPH on Days 1-4 were 0.414, 1.096, 1.162, and 0.782. In Group 2. LIF/GADPH on Days 1-4 were 0.24, 0.22, 0.35, and 0.32. CONCLUSIONS:Mouse endometrium could be effectively transfected with liposome-DNA mixtures. Endometrial LIF transfer via liposome may be effective in human.
Authors: P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen Journal: Proc Natl Acad Sci U S A Date: 1987-11 Impact factor: 11.205
Authors: M J Stewart; G E Plautz; L Del Buono; Z Y Yang; L Xu; X Gao; L Huang; E G Nabel; G J Nabel Journal: Hum Gene Ther Date: 1992-06 Impact factor: 5.695
Authors: M A Rosenfeld; W Siegfried; K Yoshimura; K Yoneyama; M Fukayama; L E Stier; P K Pääkkö; P Gilardi; L D Stratford-Perricaudet; M Perricaudet Journal: Science Date: 1991-04-19 Impact factor: 47.728
Authors: S C Hyde; D R Gill; C F Higgins; A E Trezise; L J MacVinish; A W Cuthbert; R Ratcliff; M J Evans; W H Colledge Journal: Nature Date: 1993-03-18 Impact factor: 49.962
Authors: E W Alton; P G Middleton; N J Caplen; S N Smith; D M Steel; F M Munkonge; P K Jeffery; D M Geddes; S L Hart; R Williamson Journal: Nat Genet Date: 1993-10 Impact factor: 38.330
Authors: Lusine Aghajanova; Jose A Horcajadas; James L Weeks; Francisco J Esteban; Camran N Nezhat; Marco Conti; Linda C Giudice Journal: Endocrinology Date: 2010-01-12 Impact factor: 4.736
Authors: Andrew J Ditto; John J Reho; Kush N Shah; Justin A Smolen; James H Holda; Rolando J Ramirez; Yang H Yun Journal: Mol Pharm Date: 2013-04-08 Impact factor: 4.939